This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Jacob H. Forstater, PhD
Associate Principal Scientist, Merck Process Research & Development at Merck Research Laboratories


Jacob earned his Ph.D. in Physics from UNC-Chapel Hill, where he investigated protein self-assembly and protein-surface interactions. Before joining Merck in 2016, Jacob was a postdoctoral fellow at Columbia University, where he developed key nucleotide modifications and algorithms for a nanopore-based next-generation sequencing by synthesis technology.  Jacob is currently an Associate Principal Scientist in the Enabling Technologies group within Merck’s Small Molecule PR&D department, based in Rahway, NJ.  He is responsible for the development of new enzyme immobilization technologies and approaches for immobilized biocatalysis.

Agenda Sessions

  • Harnessing IMAC to Enable an Immobilized Enzyme Cascade for the Synthesis of Islatravir


Speakers at this event